维普期刊资源整合服务平台（V6.5）

448篇 您的检索式：作者名="Mahaffey"

选中清除导出查看参考文献查看引证文献引用追踪共23页首页上一页第1页下一页末页 /23 跳转

	题名	作者	年代	出处	被引量
1	A novel two-way method for dynamically coupling a hydrodynamic model with a discrete element model(DEM)显示文摘The effect of floating objects has so far been little considered for hazard risk assessment and structure design, despite being an important factor causing structural damage in flood-prone and coastal areas. In this work, a novel two-way method is proposed to fully couple a shock-capturing hydrodynamic model with a discrete element model(DEM) for simulation of complex debris-enriched flow hydrodynamics. After being validated against an idealized analytical test, the new coupled model is used to reproduce flume experiments of floating debris driven by dam-break waves. The numerical results agree satisfactorily with the experimental measurements, demonstrating the model's capability and efficiency in simulating complex fluid-debris interactions induced by violent shallow flows.	熊焱 Qiuhua Liang Samantha Mahaffey Mohamed Rouainia 王岗	2018	Journal of Hydrodynamics2018，30，5：	3
2	ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents显示文摘	Deepak L. Bhatt James Scheiman Neena S. Abraham Elliott M. Antman Francis K.L. Chan Curt D. Furberg David A. Johnson Kenneth W. Mahaffey Eamonn M. Quigley Robert A. Harrington Eric R. Bates Charles R. Bridges Mark J. Eisenberg Victor A. Ferrari Mark A. Hl	2008	Circulation2008，，18：	3
3	Rivaroxaban versus warfarin in nonvalvular atrial fibrillation显示文摘	Patel MR Mahaffey KW Garg J		New England Journal of Medicine0，，：	2
4	Methylmercury exposure and neurotoxicity 显示文摘	Mahaffey KR	1998	JAMA1998，280，8：	2
5	Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the Platelet Inhibition and Patient Outcomes (PLATO) Trial显示文摘	Kenneth W. Mahaffey Claes Held Daniel M. Wojdyla Stefan K. James Hugo A. Katus Steen Husted Philippe Gabriel Steg Christopher P. Cannon Richard C. Becker Robert F. Storey Nardev S. Khurmi José C. Nicolau Cheuk-Man Yu Diego Ardissino Andrzej Budaj Joao Mor	2014	Journal of the American College of Cardiology2014，，：	2
6	Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective, Randomized PLATO Trial显示文摘	P. Gabriel Steg Robert A. Harrington H?kan Emanuelsson Hugo A. Katus Kenneth W. Mahaffey Bernhard Meier Robert F. Storey Daniel M. Wojdyla Basil S. Lewis Gerald Maurer Lars Wallentin Stefan K. James	2013	Circulation2013，，10：	2
7	ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use显示文摘	Deepak L. Bhatt James Scheiman Neena S. Abraham Elliott M. Antman Francis K.L. Chan Curt D. Furberg David A. Johnson Kenneth W. Mahaffey Eamonn M. Quigley Robert A. Harrington Eric R. Bates Charles R. Bridges Mark J. Eisenberg Victor A. Ferrari Mark A. Hl	2008	Journal of the American College of Cardiology2008，，18：	2
8	Mobilization of lead from the skeleton during the postnatal period is large than during pregnaney显示文摘	Gulson BL Mahaffey KR Jameson CW	1998	J Lab Cclin Med1998，131，4：	1
9	Rivaroxaban versus warfarin in nonvalvular atrial fi- brillation显示文摘	PATEL M R MAHAFFEY K W GARG J	2011	N Engl J Med2011，365，：	1
10	Rivaroxaban versus warfarin in nonvalvular atrial fibrillation显示文摘	Patel MR Mahaffey KW Garg J	2011	N Engl J Med2011，365，10：	1
11	zhe AMISTAD trial显示文摘		1999	Am Coll Cardiol 1999 Nov 151999，34，6：	1
12	Pexelizumab,an anti-C5 complement antibody,as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction:the complement inhibition in myocardial infarction treated with angioplasty (COMMA) trial显示文摘	Mahaffey KW Weaver WD	2003	Circulation2003，108，10：	1
13	Bacterial oxidation of chemical carcinogens:formation of polycyclic aromatic acids from benz (a) anthracene显示文摘	MAHAFFEY W R GIBSON D T CERMIGLA C E	1988	Applied Environmental Microbiology1988，54，：	1
14	Rivaroxaban versus warfarin in nonvalvular atrial fibrillation显示文摘	Patel MR Mahaffey K W Garg J	2011	N EnglJ Med2011，365，：	1
15	Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction :results from the CARDINAL study 显示文摘	Goyal A Mahaffey KW Garg J	2006	European Heart Journal2006，27，11：	1
16	Effect of pexelizumab,an anti-C5 complement antibody,as adjunctive therapy to fibrinolysis in acute myocardial infarction:the complement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial显示文摘	Granger CB Nicolau JC	2003	Circulation2003，108，10：	1
17	Introduction advances in lead research implications for environment health 显示文摘	MAHAFFEY K R	1990	Environ Health Perspect1990，98，1：	1
18	Rivaroxaban versus warfarin in nonvalvular at- rial fibrillation显示文摘	Patel MR Mahaffey KW Garg J	2011	N Engl J Med2011，365，10：	1
19	High-risk patients with acutecoronary syndromes treated with low-molecular-weight or unfraction-ated heparin:outcomes at 6 months and I year in the SYNERGYtrial显示文摘	Mahaffey KW Cohen M Garg J	2005	JAMA2005，294，20：	1
20	Rivaroxaban versus warfarin in nonvalvular atrial fibrillation 显示文摘	Patel MR Mahaffey KW Garg J	2011	N Engl J Med2011，365，10：	1

返回顶部每页显示：

共23页首页上一页第1页下一页末页 /23 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示